Viewing Study NCT03944902

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 3:45 AM
Ignite Modification Date: 2026-02-03 @ 5:56 AM
Study NCT ID: NCT03944902
Status: TERMINATED
Last Update Posted: 2023-11-21
First Post: 2019-05-01
Is Gene Therapy: True
Has Adverse Events: False
Brief Title: CB-839 in Combination With Niraparib in Platinum Resistant BRCA -Wild-type Ovarian Cancer Patients
Sponsor: University of Alabama at Birmingham
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Ovarian Cancer View
None Resistant BRCA Wild-Type Ovarian Cancer View
Keywords:

Keywords

Keyword Brief Keyword Text View
None BRCA Wild-Type View
None Resistant BRCA View
None Poly (ADP-ribose) polymerase (PARP) Inhibitor Therapy View